APA (7th ed.) Citation

Toyonaga, T., Kobayashi, T., Nakano, M., Saito, E., Umeda, S., Okabayashi, S., . . . Hibi, T. (2017). Usefulness of fecal calprotectin for the early prediction of short-term outcomes of remission-induction treatments in ulcerative colitis in comparison with two-item patient-reported outcome. PLoS ONE, 12(9), 1. https://doi.org/10.1371/journal.pone.0185131

Chicago Style (17th ed.) Citation

Toyonaga, Takahiko, Taku Kobayashi, Masaru Nakano, Eiko Saito, Satoko Umeda, Shinji Okabayashi, Ryo Ozaki, and Toshifumi Hibi. "Usefulness of Fecal Calprotectin for the Early Prediction of Short-term Outcomes of Remission-induction Treatments in Ulcerative Colitis in Comparison with Two-item Patient-reported Outcome." PLoS ONE 12, no. 9 (2017): 1. https://doi.org/10.1371/journal.pone.0185131.

MLA (9th ed.) Citation

Toyonaga, Takahiko, et al. "Usefulness of Fecal Calprotectin for the Early Prediction of Short-term Outcomes of Remission-induction Treatments in Ulcerative Colitis in Comparison with Two-item Patient-reported Outcome." PLoS ONE, vol. 12, no. 9, 2017, p. 1, https://doi.org/10.1371/journal.pone.0185131.